Competitive antagonism of housefly γ-aminobutyric acid receptors by iminopyridazine butanoic acids
DOI:
https://doi.org/10.3329/bjsir.v56i1.52690Keywords:
GABA receptor; Iminopyridazine butanoic acids; Housefly; Insecticides; Competitive antagonistsAbstract
The competitive antagonistic activities of a series of gabazine (3) based 3-substituted iminopyridazine butanoic acid analogs [4-(3-aryl/heteroaryl-1,6-dihydro- 6-iminopyridazin-1-yl) butanoic acid hydrochlorides] 4a-4k (Figure 1) were examined at housefly (Musca domestica) GABA receptors expressed in Xenopus oocytes using two-electrode voltage-clamp (TEVC) technique. The 4-biphenylyl analog 4e exhibited the highest inhibition (approximately 68%) of GABA-induced currents at 100 μM with an IC50 value of 40.81 ± 3.89 μM. The 2-naphthyl analog 4h was the second most active compound with approximately 48% inhibition. The 4-biphenylyl analog 4e demonstrated competitive antagonism of housefly GABA receptors. Ligand docking studies into the binding site of housefly GABA receptor homology model predicted that the aromatic 3-substituents are tolerable in the pyridazine ring. The results presented in this paper about GABA receptor competitive antagonists may helpful for design and development of GABA receptor related insecticides.
Bangladesh J. Sci. Ind. Res.56(1), 9-16, 2021
Downloads
25
29
Downloads
Published
How to Cite
Issue
Section
License
Bangladesh Council of Scientific and Industrial Research (BCSIR) holds the copyright to all contents published in Bangladesh Journal of Scientific and Industrial Research (BJSIR). A copyright transfer form should be signed by the author(s) and be returned to BJSIR.
The entire contents of the BJSIR are protected under Bangladesh Council of Scientific and Industrial Research (BCSIR) copyrights.
BJSIR is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial License (CC BY-NC) Creative Commons Attribution-NonCommercial 4.0 International License which allows others remix, tweak, and build upon the articles non-commercially, and although their new works must also acknowledge and be non-commercial, they dont have to license their derivative works on the same terms.